Mometason furoate is a glucocorticoid or corticosteroid used topically to reduce inflammation of the skinor in the airways. It is a prodrug of the free form mometason (INN).
Mometason furoate is used in the treatment of inflammatory skin disorders (such as eczema and psoriasis) (topical form), allergic rhinitis (such as hay fever) (topical form), asthma (inhalation form) for patients unresponsive to less potent corticosteroids, and penile phimosis. In terms of steroid strength, it is more potent than hydrocortisone, and less potent than dexamethasone.
Some low-quality evidence suggests the use of mometason for symptomatic improvement in children with adenoid hypertrophy.
Mometason is used to alleviate inflammation and itchiness in skin conditions that respond to treatment with glucocorticoids such as psoriasis and atopic dermatitis.
Nasal mometason is used in adults (including the elderly) and children over two years of age, to diminish the symptoms such as hay fever (seasonal allergic rhinitis) and other allergies (perennial rhinitis), including nasal congestion, discharge, pruritus, and sneezing and to treat nasal polyps.
Asthma
Mometason furoate can be used with formotero for the treatment of asthma, due to its anti-inflammatory properties.